Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia.
Authors: Herrmann M; Gene Center and Department of Biochemistry., Krupka C; Department of Medicine III, University Hospital, and.; Gene Center Munich, Laboratory of Translational Cancer Immunology, Ludwig-Maximillians-Universität München, Munich, Germany., Deiser K; Department of Medicine III, University Hospital, and.; Gene Center Munich, Laboratory of Translational Cancer Immunology, Ludwig-Maximillians-Universität München, Munich, Germany., Brauchle B; Department of Medicine III, University Hospital, and.; Gene Center Munich, Laboratory of Translational Cancer Immunology, Ludwig-Maximillians-Universität München, Munich, Germany., Marcinek A; Department of Medicine III, University Hospital, and.; Gene Center Munich, Laboratory of Translational Cancer Immunology, Ludwig-Maximillians-Universität München, Munich, Germany., Ogrinc Wagner A; Department of Medicine III, University Hospital, and.; Gene Center Munich, Laboratory of Translational Cancer Immunology, Ludwig-Maximillians-Universität München, Munich, Germany., Rataj F; Center for Integrated Protein Science Munich, Munich, Germany.; Division of Clinical Pharmacology, Department of Internal Medicine IV, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany., Mocikat R; Institute of Molecular Immunology and.; Research Unit Translational Molecular Immunology, Helmholtz Zentrum München, Munich, Germany., Metzeler KH; Department of Medicine III, University Hospital, and., Spiekermann K; Department of Medicine III, University Hospital, and.; German Cancer Consortium (DKTK), Munich, Germany; and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Kobold S; Center for Integrated Protein Science Munich, Munich, Germany.; Division of Clinical Pharmacology, Department of Internal Medicine IV, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany., Fenn NC; Gene Center and Department of Biochemistry., Hopfner KP; Gene Center and Department of Biochemistry.; Center for Integrated Protein Science Munich, Munich, Germany., Subklewe M; Department of Medicine III, University Hospital, and.; Gene Center Munich, Laboratory of Translational Cancer Immunology, Ludwig-Maximillians-Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany; and.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Source: Blood [Blood] 2018 Dec 06; Vol. 132 (23), pp. 2484-2494. Date of Electronic Publication: 2018 Oct 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood-2018-05-849802